Global Immobilized Trypsin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Immobilized Trypsin provides a fast and convenient method for digesting a range of concentrations of purified protein or complex protein mixtures. Digested peptides are easily separated from the Immobilized Trypsin as they flow through the spin column into the collection tube. Immobilized Trypsin is easily removed from the peptide solution because the trypsin does not pass though the column frit. Trypsin is a proteolytic enzyme, which cleaves at the carboxyl side of positively charged Lysine (Lys) and Arginine (Arg). When these amino acids are followed by the nonpolar Proline (Pro), the digestion of the site is not efficient. When Lys and Arg are followed by acids [Aspartic Acid (Asp) and Glutamic Acid (Glu)] the digestion is also not as efficient.
According to our (Global Info Research) latest study, the global Immobilized Trypsin market size was valued at US$ 10.9 million in 2023 and is forecast to a readjusted size of USD 15.8 million by 2030 with a CAGR of 5.5% during review period.
North American is the largest consumption place, with a consumption market share nearly 45% in 2019. Following North American, Europe is the second with the market share of 28.39%.
Market competition is intense. Promega, Thermo Scientific, G-Biosciences, SignalChem and Takara, etc. are the leaders of the industry, and they hold key patents, with high-end customers. Top 5 occupied 3/5 of the market in 2019.
According to the form, the classification of Immobilized Trypsin includes 2 ml, 4ml, etc. In addition, the proportion of 2 ml in 2019 is about 70.63%.
Immobilized Trypsin is widely used for Academic & Research Institutes and Pharmaceutical Companies. The most proportion of Immobilized Trypsin is used for Academic & Research Institutes, and the proportion in 2019 is about 62.15%.
This report is a detailed and comprehensive analysis for global Immobilized Trypsin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Immobilized Trypsin market size and forecasts, in consumption value ($ Million), sales quantity (K Unit), and average selling prices (USD/Unit), 2019-2030
Global Immobilized Trypsin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Unit), and average selling prices (USD/Unit), 2019-2030
Global Immobilized Trypsin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Unit), and average selling prices (USD/Unit), 2019-2030
Global Immobilized Trypsin market shares of main players, shipments in revenue ($ Million), sales quantity (K Unit), and ASP (USD/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Immobilized Trypsin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Immobilized Trypsin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Promega, Thermo Scientific, G-Biosciences, SignalChem, Takara, GoldBio, Creative Enzymes, ProteoChem, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Immobilized Trypsin market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
2 ml
4 ml
Others
Market segment by Application
Academic & Research Institutes
Pharmaceutical Companies
Major players covered
Promega
Thermo Scientific
G-Biosciences
SignalChem
Takara
GoldBio
Creative Enzymes
ProteoChem
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Immobilized Trypsin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Immobilized Trypsin, with price, sales quantity, revenue, and global market share of Immobilized Trypsin from 2019 to 2024.
Chapter 3, the Immobilized Trypsin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Immobilized Trypsin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Immobilized Trypsin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Immobilized Trypsin.
Chapter 14 and 15, to describe Immobilized Trypsin sales channel, distributors, customers, research findings and conclusion.